Pharmaceutical Investing Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien® in Canada
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets
Q BioMed Inc. Advisor and Mannin Research Inc CSO Dr Susan Quaggin Discusses Glaucoma and Man-01 with Eye on Vision Radio
EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation and Pain Post Cataract Surgery
Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due to Tremendous Strong Demand from Institutions and Accredited Investors
CoTec Holdings Corp. To Commence Expansion Drilling Program And Secure A Salter Techology Bulk Sample At The Lac Jeannine Property
